UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 176

Sortiert nach

Serum zonulin levels in patients with liver cirrhosis: Prognostic implications

World journal of hepatology, 2021-10, Vol.13 (10), p.1394-1404

2021

Volltextzugriff (PDF)

Letter: do interferon lambda 3 polymorphisms predict the outcome of interferon therapy in hepatitis B infection?

Alimentary pharmacology & therapeutics, 2014-05, Vol.39 (10), p.1250-1251

2014

Volltextzugriff (PDF)

Long-term safety of anti-TNF treatment in patients with rheumatic diseases and chronic or resolved hepatitis B virus infection

Annals of the rheumatic diseases, 2010-07, Vol.69 (7), p.1352-1355

2010

Volltextzugriff (PDF)

Serum HBsAg kinetics and usefulness of interferon-inducible protein 10 serum in HBeAg-negative chronic hepatitis B patients treated with tenofovir disoproxil fumarate

Journal of viral hepatitis, 2015-12, Vol.22 (12), p.1079-1087

2015

Volltextzugriff (PDF)

SAT0484 Long-Term Safety of non-TNF Inhibitor Biologics in Rheumatoid Arthritis Patients with Chronic or Past Hepatitis B Virus Infection

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.845-846

2016

Volltextzugriff (PDF)

Serum hepcidin levels are related to the severity of liver histological lesions in chronic hepatitis C

Journal of viral hepatitis, 2010-11, Vol.17 (11), p.800-806

2010

Volltextzugriff (PDF)

High Lipopolysaccharide Binding Protein Levels are Related to Intermediate Mortality in Patients with Decompensated Cirrhosis

Journal of hepatology, 2016, Vol.64 (2), p.S247-S248

2016

Volltextzugriff (PDF)

Longitudinal changes in serum HBV DNA levels and predictors of progression during the natural course of HBeAg-negative chronic hepatitis B virus infection

Journal of viral hepatitis, 2008-06, Vol.15 (6), p.434-441

2008

Volltextzugriff (PDF)

High serum human beta-defensin-1 is associated with increased short-term mortality in patients with decompensated cirrhosis

Journal of hepatology, 2017, Vol.66 (1), p.S123-S124

2017

Volltextzugriff (PDF)

AB0108 Increased Expression of GM-CSF Secreting Peripheral B Cells in Patients with Rheumatoid Arthritis

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.839-840

2014

Volltextzugriff (PDF)

Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection

Gut, 2008-04, Vol.57 (4), p.500-506

2008

Volltextzugriff (PDF)

AB0363 Rate of tuberculin skin test or interferon gamma release assay conversion during anti-tumor necrosis factor therapy in rheumatic patients

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.658-658

2013

Volltextzugriff (PDF)

Serum HCV RNA levels and HCV genotype do not affect insulin resistance in nondiabetic patients with chronic hepatitis C: a multicentre study

Alimentary pharmacology & therapeutics, 2009-11, Vol.30 (9), p.947-954

2009

Volltextzugriff (PDF)

Cellular immune responses in hepatitis B virus e antigen negative chronic hepatitis B

Journal of viral hepatitis, 2008-11, Vol.15 (11), p.817-826

2008

Volltextzugriff (PDF)

731 CHANGES OF SERUM APOPTOTIC CASPASE ACTIVITY IN HBEAG-NEGATIVE CHRONIC HEPATITIS B (CHB) PATIENTS UNDER ORAL ANTIVIRAL THERAPY

Journal of hepatology, 2010, Vol.52, p.S284-S285

2010

Volltextzugriff (PDF)

DARING-B: discontinuation of effective entecavir or tenofovir disoproxil fumarate long-term therapy before HBsAg loss in non-cirrhotic HBeAg-negative chronic hepatitis B

Antiviral therapy, 2018-01, Vol.23 (8), p.677-685

2018

Volltextzugriff (PDF)

[480] LONGITUDINAL CHANGES IN SERUM HBV-DNA LEVELS DURING THE NATURAL COURSE OF HBeAg-NEGATIVE CHRONIC HEPATITIS B VIRUS (HBV) INFECTION

Journal of hepatology, 2007, Vol.46, p.S182-S182

2007

Volltextzugriff (PDF)

THU-271 - Human beta-defensin-1 is a highly predictive marker of mortality in patients with acute-on-chronic liver failure

Journal of hepatology, 2018-04, Vol.68, p.S251-S251

2018

Volltextzugriff (PDF)

Human beta-defensin-1 is a highly predictive marker of mortality in patients with acute-on-chronic liver failure

Journal of hepatology, 2018-04, Vol.68, p.S251

2018

Volltextzugriff (PDF)

Severe hepatitis C virus‐related cryoglobulinaemic sensory–motor polyneuropathy treated with pegylated interferon‐a2b and ribavirin: clinical, laboratory and neurophysiological study

Liver international, 2007-04, Vol.27 (3), p.414-420

2007

Volltextzugriff (PDF)

THU-013 - High serum human beta-defensin-1 is associated with increased short-term mortality in patients with decompensated cirrhosis

Journal of hepatology, 2017, Vol.66 (1), p.S123-S124

2017

Volltextzugriff (PDF)

[749] SERUM APOPTOTIC CASPASE ACTIVITY AS MARKER OF DISEASE SEVERITY IN CHRONIC HEPATITIS C (CH-C) OR NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)

Journal of hepatology, 2007, Vol.46, p.S282-S282

2007

Volltextzugriff (PDF)

[768] THE SIGNIFICANCE OF LEPTIN, ADIPONECTIN, AND RESISTIN SERUM LEVELS IN CHRONIC LIVER DISEASES

Journal of hepatology, 2007, Vol.46, p.S288-S288

2007

Volltextzugriff (PDF)

PS-159 - Rates and predictors of HBsAg loss after discontinuation of effective long-term Entecavir or Tenofovir therapy in noncirrhotic HBeAg-negative chronic hepatitis B patients: Results from the DARING-B prospective Greek study

Journal of hepatology, 2018-04, Vol.68, p.S88-S89

2018

Volltextzugriff (PDF)

Rates and predictors of HBsAg loss after discontinuation of effective long-term Entecavir or Tenofovir therapy in noncirrhotic HBeAg-negative chronic hepatitis B patients: Results from the DARING-B prospective Greek study

Journal of hepatology, 2018-04, Vol.68, p.S88-S89

2018

Volltextzugriff (PDF)

1 – 25 von 176

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(172)
Mit Volltextzugriff
(161)

Publikationsform

Sprache

Englisch
(176)
Japanisch
(15)

Erscheinungsjahr

n.n

Thema

Humans
(90)
Science & Technology
(88)
Life Sciences & Biomedicine
(87)
Female
(63)
Male
(63)
Middle Aged
(57)
Biological And Medical Sciences
(56)
Adult
(55)
Medical Sciences
(52)
Gastroenterology & Hepatology
(50)
Infectious Diseases
(36)
Aged
(32)
Adolescent
(22)
Viral Hepatitis
(22)
Human Viral Diseases
(21)
Viral Diseases
(21)
Antiviral Agents - Therapeutic Use
(19)
Hepatitis B, Chronic - Drug Therapy
(19)
Pharmacology. Drug Treatments
(19)
Virology
(18)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Serum zonulin levels in patients with liver cirrhosis: Prognostic implications

Letter: do interferon lambda 3 polymorphisms predict the outcome of interferon therapy in hepatitis B infection?

Long-term safety of anti-TNF treatment in patients with rheumatic diseases and chronic or resolved hepatitis B virus infection

Serum HBsAg kinetics and usefulness of interferon-inducible protein 10 serum in HBeAg-negative chronic hepatitis B patients treated with tenofovir disoproxil fumarate

SAT0484 Long-Term Safety of non-TNF Inhibitor Biologics in Rheumatoid Arthritis Patients with Chronic or Past Hepatitis B Virus Infection

Serum hepcidin levels are related to the severity of liver histological lesions in chronic hepatitis C

High Lipopolysaccharide Binding Protein Levels are Related to Intermediate Mortality in Patients with Decompensated Cirrhosis

Longitudinal changes in serum HBV DNA levels and predictors of progression during the natural course of HBeAg-negative chronic hepatitis B virus infection

High serum human beta-defensin-1 is associated with increased short-term mortality in patients with decompensated cirrhosis

AB0108 Increased Expression of GM-CSF Secreting Peripheral B Cells in Patients with Rheumatoid Arthritis

Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection

AB0363 Rate of tuberculin skin test or interferon gamma release assay conversion during anti-tumor necrosis factor therapy in rheumatic patients

Serum HCV RNA levels and HCV genotype do not affect insulin resistance in nondiabetic patients with chronic hepatitis C: a multicentre study

Cellular immune responses in hepatitis B virus e antigen negative chronic hepatitis B

731 CHANGES OF SERUM APOPTOTIC CASPASE ACTIVITY IN HBEAG-NEGATIVE CHRONIC HEPATITIS B (CHB) PATIENTS UNDER ORAL ANTIVIRAL THERAPY

DARING-B: discontinuation of effective entecavir or tenofovir disoproxil fumarate long-term therapy before HBsAg loss in non-cirrhotic HBeAg-negative chronic hepatitis B

[480] LONGITUDINAL CHANGES IN SERUM HBV-DNA LEVELS DURING THE NATURAL COURSE OF HBeAg-NEGATIVE CHRONIC HEPATITIS B VIRUS (HBV) INFECTION

THU-271 - Human beta-defensin-1 is a highly predictive marker of mortality in patients with acute-on-chronic liver failure

Human beta-defensin-1 is a highly predictive marker of mortality in patients with acute-on-chronic liver failure

Severe hepatitis C virus‐related cryoglobulinaemic sensory–motor polyneuropathy treated with pegylated interferon‐a2b and ribavirin: clinical, laboratory and neurophysiological study

THU-013 - High serum human beta-defensin-1 is associated with increased short-term mortality in patients with decompensated cirrhosis

[749] SERUM APOPTOTIC CASPASE ACTIVITY AS MARKER OF DISEASE SEVERITY IN CHRONIC HEPATITIS C (CH-C) OR NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)

[768] THE SIGNIFICANCE OF LEPTIN, ADIPONECTIN, AND RESISTIN SERUM LEVELS IN CHRONIC LIVER DISEASES

PS-159 - Rates and predictors of HBsAg loss after discontinuation of effective long-term Entecavir or Tenofovir therapy in noncirrhotic HBeAg-negative chronic hepatitis B patients: Results from the DARING-B prospective Greek study

Rates and predictors of HBsAg loss after discontinuation of effective long-term Entecavir or Tenofovir therapy in noncirrhotic HBeAg-negative chronic hepatitis B patients: Results from the DARING-B prospective Greek study

Suchergebnisse filtern